Oct 30, 2006 by Ralph CasaleSigma-Aldrich Ekes Out Organic GrowthShare buybacks and a dividend help offset some mixed news.
Oct 5, 2006 by Ralph CasaleRNAi: Nobel Prize-Winning BiotechnologyDrugs based on the technology have a long way to go, but the future does look promising.
Sep 28, 2006 by Ralph CasaleA Second Sell-Off at Molecular DevicesThe company, which makes equipment used in drug development, is struggling with lumpy revenues.
Sep 26, 2006 by Ralph CasaleBiotech's Distant StarCepheid still isn't a profitable company, but strong sales growth should continue.
Aug 30, 2006 by Ralph CasaleFoolish Book Review: "The Future for Investors"Will the future be as good as the past might have been?
Aug 25, 2006 by Ralph CasaleAdams Coughs Up Some ProfitsAdams Respiratory Therapeutics isn't suffering any off-seasonal ills.
Aug 15, 2006 by Ralph CasaleSirna Battles Genes Gone BadPharmaceutical start-up Sirna Therapeutics tests drugs to silence rogue genes.
